Statistical considerations when assessing outcomes following treatment for prostate cancer.

[1]  J. Hanley,et al.  Competing risk analysis of men aged 55 to 74 years at diagnosis managed conservatively for clinically localized prostate cancer. , 1999, JAMA.

[2]  J. Hanley,et al.  Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer , 1998 .

[3]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[4]  L. Holmberg,et al.  Fifteen-year survival in prostate cancer. A prospective, population-based study in Sweden. , 1997, JAMA.

[5]  E. Feuer,et al.  Changing trends in U.S. prostate cancer incidence rates. , 1996, Journal of the National Cancer Institute.

[6]  L. Holmberg,et al.  Trends in prostate cancer survival in Sweden, 1960 through 1988: evidence of increasing diagnosis of nonlethal tumors. , 1996, Journal of the National Cancer Institute.

[7]  P. Schellhammer,et al.  Results of radical prostatectomy in men with clinically localized prostate cancer. , 1996, JAMA.

[8]  A. Partin,et al.  Extended followup of the influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer and extensive capsular perforation. , 1996, The Journal of urology.

[9]  M. Barry,et al.  Follow-up prostate cancer treatments after radical prostatectomy: a population-based study. , 1996, Journal of the National Cancer Institute.

[10]  D. Fryback,et al.  Long-term survival among men with conservatively treated localized prostate cancer. , 1995, JAMA.

[11]  J. Hugosson,et al.  Long-term survival and mortality in prostate cancer treated with noncurative intent. , 1995, The Journal of urology.

[12]  R H Brook,et al.  Quality-of-life outcomes in men treated for localized prostate cancer. , 1995, JAMA.

[13]  A. Partin,et al.  Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years. , 1994, The Journal of urology.

[14]  S. Hancock,et al.  Control of prostate cancer with radiotherapy: long-term results. , 1994, The Journal of urology.

[15]  R. Thisted,et al.  Results of conservative management of clinically localized prostate cancer. , 1994, The New England journal of medicine.

[16]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[17]  A R Feinstein,et al.  The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. , 1985, The New England journal of medicine.

[18]  C. Percy,et al.  Accuracy of cancer death certificates and its effect on cancer mortality statistics. , 1981, American journal of public health.

[19]  Taylor Murray,et al.  Cancer statistics, 1998 , 1998, CA: a cancer journal for clinicians.

[20]  P. Walsh,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer: a multi-institutional update. , 1997, The Journal of urology.

[21]  M. Kulldorff,et al.  Re: Long-term survival and mortality in prostate cancer treated with noncurative intent. , 1996, The Journal of urology.

[22]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.